The role of neurohormonal blockers in the primary prevention of acute-, early-, and late-onset anthracycline-induced cardiotoxicity
Abstract Background Anthracycline-induced cardiotoxicity has been classified based on its onset into acute, early, and late. It may have a significant burden on the quality and quantity of life of those exposed to this class of medication. Currently, there are several ongoing debates on the role of...
Main Authors: | Ahmed Ayuna, Nik Abidin |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-09-01
|
Series: | The Egyptian Heart Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s43044-020-00090-0 |
Similar Items
-
Beta-blockers for the primary prevention of anthracycline-induced cardiotoxicity: a meta-analysis of randomized controlled trials
by: Yingxu Ma, et al.
Published: (2019-04-01) -
Preventive use of beta-blockers for anthracycline-induced cardiotoxicity: A network meta-analysis
by: Dongsheng He, et al.
Published: (2022-08-01) -
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
by: Neha Bansal, et al.
Published: (2019-12-01) -
Cardioprotective Agents for the Primary Prevention of Trastuzumab-Associated Cardiotoxicity: A Systematic Review and Meta-Analysis
by: Kyriakos Goulas, et al.
Published: (2023-07-01) -
Dexrazoxane in anthracycline cardiotoxicity
by: Abhijit S Nair
Published: (2017-01-01)